SUPPLEMENTAL FIGURE LEGENDS !
, Related to Figure 2. The Eif4a1(F163L) allele does not confer cross-resistance to Hippuristanol. a. Chemical structure of compounds used in this study. b. Cell viability following exposure of NIH/3T3 cells to the indicated concentrations of silvestrol or (-)-SDS-1-021. Cells were exposed to the indicated concentrations of compound for 4 days and viability assessed by the SRB assay. N= 3 biological replicates performed in duplicates ± SEM. c. Cell viability following exposure of NIH/3T3 cells transduced with the indicated retroviruses. Cells were cultured for 4 days in the presence of the indicated concentrations of hippuristanol and relative growth assessed using the SRB assay. N=2 technical replicates ± SD. em1JP (Myr-Akt) or eIF4A1 em1JP (Myr-Akt#1) cells were labeled with 35 SMet/Cys for 5 hours in the presence of 10 nM silvestrol. IPs were performed using equal amounts of protein (500 µg). Following IPs, samples were resolved by SDS-PAGE, and the gels were treated with EN 3 HANCE (Perkin Elmer, MA), dried and exposed to X-ray film. A representative autoradiograph of the resulting immunoprecipitated proteins with the position of migration of c-MYC and the c-MYC interacting protein, MAX, indicated. The relative c-MYC band intensities are shown to the right. N=2 biological replicates ± SD. 
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Exon 5 Exon 6 Exon 4 5' 3' ...GGTACCCCTGGCCGGGTGTTTGACATGCTTAACCGGAGATAC....
...GGTACCCCTGGACGGGTGCTCGACATGCTTAACCGCAGATAC...
CTC (1):
...GGTACCCCTGGCCGGGTGCTCGACATGCTTAACCGGAGATAC... CTC (3) 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Compounds. Silvestrol was synthesized as previously reported (Gerard et al., 2007; Rodrigo et al., 2012) . The rocaglate hydroxamate (-)-SDS-1-021 was generated using biomimeic kinetic resolution of chiral, racemic aglain ketone precursors (Stone et al., 2015) followed by amide formation (Gerard et al., 2006) . Hippuristanol was synthesized as previously described (Somaiah et al., 2014) .
Purification of Recombinant eIF4A1
Protein. Recombinant eIF4A1 protein was purified as previously described (Cencic et al., 2012) . Briefly, BL21 (DE3) codon+ E. coli cells were transformed with pET15b-His 6 -eIF4A1, cultured at 37°C until the OD 600 reached 0.6, and induced with 1 mM IPTG for 3 h. Recombinant His 6 -eIF4A1 was enriched on a Ni 2+ -NTA agarose column and then further purified on a Q-Sepharose fast flow matrix and eluted with a linear salt gradient (100-500 mM KCl). Fractions containing recombinant His 6 -eIF4A1 were pooled and dialyzed against Buffer A (20 mM Tris-Cl [pH 7.5], 10% glycerol, 0.1 mM EDTA) overnight at 4°C.
Competition Assay. Transduced NIH/3T3 cells were mixed with an equal number of untransduced cells and cultured in 12 well plates in the presence of the indicated concentrations of compound. Every two days, cells were trypsinized and the relative population of GFP positive cells determined by flow cytometry (Guava EasyCyte, Millipore).
Sulforhodamine B (SRB) Assay. One thousand cells were seeded per well in a 96-well plate and cultured in various concentrations of compound or vehicle (DMSO) for 6 days. To assay for relative viability, cells were washed with PBS, fixed with 50% TCA for 1 h, then stained with 0.4% SRB for 10 minutes. Plates were washed 4 times with 1% acetic acid, dried, and the remaining dye was resuspended in 200 µl of 10 mM Tris base [pH 10.5] per well. The OD 510nm was measured using a microplate reader (SpectraMax M5, Molecular Devices) and relative viability was calculated by normalizing to the DMSO control.
Cell Doubling Assay. Ten thousand cells were seeded in 12 well plates at the beginning of each passage. Two days later, cells were trypsinized, counted by flow cytometry (GUAVA EasyCyte Plus; Millipore), and reseeded. Population doubling levels for each passage was calculated as follows: Cumulative PDL= [Log(Final cell number/Initial cell number)/Log(2)]+Starting PDL) (Faraonio et al., 2012; Hayflick, 1973) .
Colony Formation Assay. Five hundred cells were seeded per well in a 12 well plate and 48 h postseeding the indicated amounts of silvestrol or DMSO was added to the cells. Cells were cultured under these conditions for another 14 days, with the media being changed every 3 days. Wells were washed with PBS and colonies fixed for 10 min with ice-cold methanol. The colonies were stained with 0.4% methylene blue solution (in 50% methanol). Wells were washed five times with water and then dried at room temperature.
Western Blots Cells were lysed in RIPA buffer (20 mM Tris [pH 7.6], 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP40, 0.5% Sodium Deoxycholate, 0.1% SDS, 1 mM PMSF, 4 µg/ml aprotinin, 2 µg/ml leupeptin, 2 µg/ml pepstatin), resolved on a 10% Nu-PAGE gel, and transferred to a PVDF membrane (Bio-Rad). For Western blots probing for c-MYC, nuclear extracts were prepared by resuspending pelleted cells into cytoplasmic lysis buffer (50 mM Tris at pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100), followed by centrifugation at 14000 rpm for 10 minutes to isolate the nuclei. The pelleted nuclei were then lysed using RIPA buffer and equal protein was loaded onto 10% Nu-PAGE gels. Antibodies used in this study were directed against the following: His 6 -tag (27-4710-01, GE Healthcare Life Sciences), eIF4A1 (ab31217, Abcam), eIF4A2 (ab31218, Abcam), eEF2 (#9742, Cell Signaling), GAPDH (ab8245, Abcam), c-Myc (N262, Santa Cruz), and actin (A5316, Sigma-Aldrich).
[
35 S]-Methionine/Cysteine Metabolic Labeling. Cells were incubated in methionine/cysteine-free DMEM supplemented with 10% dialyzed FBS, 100 U/ml penicillin/streptomycin and 2 mM LGlutamine in the presence of the indicated concentration of compound or vehicle (DMSO) for 45 min prior to the addition of [ 35 S]-methionine/cysteine (150-200 µCi/ml) (Perkin Elmer, Waltham, MA). The incubations were continued for an additional 15 min and extracts were prepared by lysing the cells in RIPA buffer. Radiolabeled proteins were precipitated onto 3 MM Whatman paper using trichloroacetic acid, and quantitated by scintillation counting. CPMs were normalized to total protein as determined by the DC assay (Bio-Rad) and plotted relative to the values obtained from the DMSO controls.
eIF4A1 Functional Assays. ATPase assays were performed as previously described using Condition B (Lorsch and Herschlag, 1998) . In essence, 1 µM [ 32 P]-ATP (10 Ci/mmol) (unless indicated otherwise) was added to a buffer containing 1 µg of purified recombinant protein, 2.5 mM MgCl 2 , 1 mM DTT, 1% glycerol, 20 mM MES-KOH [pH 6.0], 10 mM KOAc, 2.5 µM poly (U) RNA, and 50 µM silvestrol or DMSO. Reactions were incubated at 25°C for 60 min (unless indicated otherwise) and quenched by adding EDTA to a final concentration of 2.5 mM. Reactions were then resolved on PEIcellulose TLC plates using 1 M LiCl/0.3 M NaH 2 PO 4 as the developing solvent. The extent of ATP hydrolysis was quantitated using a Typhoon Trio Imager (GE Healthcare). Experiments used to determine kinetic parameters of eIF4A1 ATP hydrolysis were performed under the conditions described above with varying concentrations of ATP (each reaction contained 1 µM [ 32 P]-ATP mixed with the appropriate amount of unlabeled ATP) and 2 µl of the reaction was removed and quenched at 0, 2.5, 7.5, 12.5, and 17.5 min after addition of ATP. ATP hydrolysis of each time point was quantitated and plotted with respect to time in order to determine the V initial for each ATP concentration. V initial values were then plotted with respect to ATP concentration and the K m and V max values determined by fitting the curves to the Michaelis-Menten model on GraphPad Prism (v5.0a).
For RNA binding assays, body-labeled [ 32 P]-RNA was generated from pSP/CAT linearized with PvuII. Following in vitro transcription with SP6 RNA Polymerase, an RNA of 157 nucleotides is produced [ 5' pppGAATACAAGCTTGGCGAGATTTTCAGGAGCTAAGGAAGCTAAAATGGAGA AAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACATTTTGA GGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAG 3' ] Gorman, 1985) . RNA binding assays were performed by incubating 3 µg recombinant protein with body labeled [ 32 P]-RNA (35000 cpm) in binding buffer (25 mM Tris [pH 7.5], 1 mM DTT, 100 mM KCl, 1 mM ATP, 5 mM MgCl 2 ) in the presence of DMSO or 1 µM silvestrol at 37°C for 10 min. Binding reactions were stopped by the addition of ice-cold wash buffer (25 mM Tris [pH 7.5], 100 mM KCl, 3 mM MgCl 2 ) and then applied onto a nitrocellulose filter (45 µM HA Millipore) (preblocked with 0.1% sodium pyrophosphate). Filters were washed 3 times with wash buffer and dried prior to scintillation counting in order to assess the amount of [ 32 P]-labeled RNA retained on the filter. Helicase assays were performed as previously published (Rogers et al., 1999) . Briefly 0.5 µg of recombinant protein was added to a 20 µl reaction buffer containing DMSO or 50 µM silvestrol, 2 nM of [
32 P]-RNA-11 duplex (Rogers et al., 1999) , 20 mM HEPES-KOH [pH 7.5], 70 mM KCl, 20 mM DTT, 10 mM Mg(OAc) 2 , 1 mg/ml acetylated BSA, and 1 mM ATP. Reactions were incubated at 35°C for 15 min and terminated by adding 5 µl of a solution containing 50% glycerol, 2% SDS, 20 mM EDTA, and Bromophenol Blue and Xylene Cyanol dyes. The products of the helicase assays were resolved on a 12% polyacrylamide gel, dried and quantitated using a Typhoon Trio Imager (GE Healthcare).
Differential Scanning Fluorimetry (DSF).
Experiments were performed as previously reported (Niesen et al., 2007) with slight modifications to the buffer conditions. Briefly, 2.1 µM of recombinant eIF4A1 (wild type or F163L) was incubated with compound or DMSO in DSF buffer (20 mM HEPES-KOH [pH 7.5], 70 mM KCl, 2 mM DTT, 1 mM Mg(OAc) 2 , 1 mM ATP, 7.5X Sypro Orange (S-6650, Thermo Fisher), and 0.7 µM RNA-1 (Rogers et al., 1999) . The samples were heated and read from 25°C to 70°C at 1 °C/min ramp rate using the CFX96 Touch™ Real-Time PCR Detection System (BioRad). Data analysis was performed as previously described (Niesen et al., 2007) .
Cas9-mediated Editing of Eif4a1. Targeting of the Eif4a1 locus was undertaken using a previously described pQCX-based vector system (Malina et al., 2013) expressing human codon-optimized Cas9, GFP, and an sgRNA targeting Eif4a1 exon 5. A single stranded oligonucleotide (ssODN) harboring the desired F136L change, a novel TaqI site, and mutated PAMs was used as template. DNA was introduced into NIH/3T3 cells by nucleofection of 2.5 µg of plasmid and 0.3 ng of ssODN (Amaxa Cell Line Nucleofector KitR for NIH/3T3, VCA-1001, Lonza). After 48h, cells were placed in media containing 80 nM silvestrol. Two days later, individual colonies were isolated and characterized by restriction digest analysis. Characterization of the Eif4a1 locus was determined via PCR amplification of the targeted locus using the following primers: Eif4a1ex5-1 fwd 5'-AACTTGCATCCAAGAAAATGACA-3', Eif4a1ex5-1 rev 5'-AGAAGCTGCAGATGGAAGCTC-3'. To determine allele frequencies, the PCR product was then cloned into pBluescript KS II, transformed into DH10β cells, and single colonies were picked for mini-prepping and sequencing. Direct sequencing of the Eif4a1 locus was also performed on PCR products amplified by the following primers:
Eif4a1ex5-2 fwd 5'-ATGTGGTAGTAGGGTGGAGAGT-3', Eif4a1ex5-2 rev 5'GCATCCAAGAAAATGACATGTGGG-3' Cellular Thermal Shift Assay (CETSA). Experiments were performed essentially as described (Jafari et al., 2014) . Briefly, 5 x 10 6 cells were seeded into a 15 cm dish and on the following day were exposed to 1 µM (-)-SDS-1-021 or DMSO for 1 h. Cells were pelleted, washed twice with PBS (containing 1 µM (-)-SDS-1-021 or DMSO), resuspended in PBS (containing 1 µM (-)-SDS-1-021 or DMSO) and distributed into a 96 well PCR plate (Axygen). Cells were heated to the indicated temperatures for 3 min using a PCR machine (Mastercycler Pro, Eppendorf) and then cooled to RT for 3 min. Cells were lysed by 3 freeze/thaw cycles and the insoluble fraction pelleted by centrifugation at 14000 rpm for 10 min. Equivalent volumes of the soluble fraction was resolved on a 10% Nu-PAGE gel and transferred to a PVDF membrane for Western blotting. Quantitations were performed using the Li-COR Odyssey Imaging System (v3.0). Relative soluble eIF4A1 levels were determined by normalizing band intensities to the highest intensity value obtained in the set. The aggregation temperatures (as defined by the temperature where 50% of the protein is denatured) were determined by fitting the curves to the Boltzmann Sigmoidal function.
Polysome Analysis and RT-qPCR analysis of mRNA. Cells were incubated with the indicated concentration of compound for 1 h and washed twice with ice-cold PBS supplemented with 100 µg/ml cycloheximide. Cells were pelleted and lysed with hypotonic lysis buffer (5 mM Tris-HCl [pH 7.5], 2.5 mM MgCl 2 , 1.5 mM KCl, 2 mM DTT, 1% Triton X-100, 0.5% sodium deoxycholate, 100 µg/ml cycloheximide) and the subsequent extract was loaded onto a 10-50% sucrose gradient. Samples were centrifuged at 35000 rpm for 2:15 hours at 4°C and the gradients were then fractionated while reading the UV 254 absorbance. RNA was extracted from each fraction using TRIzol (Life Technologies) according to the manufacturer's instructions. SuperScript III reverse transcriptase (Invitrogen) and oligo(dT) 20 primers were used generate cDNAs and qPCRs were performed with SsoFast Evagreen Supermix (Bio-Rad) using the CFX96 PCR system. The following primers were used: myc fwd 5'-ATTTCCTTTGGGCGTTGGA-3', myc rev 5'-TCCTGTTGGTGAAGTTCACGTT-3', Atp5o fwd 5'-TCTCGACAGGTTCGGAGCTT-3', Atp5o rev 5'-AGAGTACAGGGCGGTTGCATA-3'.
